Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%
31 December 2025
2 mins read

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

NEW YORK, December 31, 2025, 07:54 ET — Premarket

  • Under Armour shares held near Tuesday’s close after a filing showed Fairfax Financial raised its stake in the sportswear maker
  • Fairfax-controlled entities bought about 15.7 million Under Armour shares across two classes in late December, a Form 4 showed
  • Investors are watching whether the buying continues and for the company’s next quarterly update in early 2026

Under Armour shares held near $5 in premarket indications on Wednesday after filings showed Fairfax Financial Holdings, led by investor V. Prem Watsa, increased its stake in the sportswear maker. Under Armour’s Class A shares (UAA) last closed at $5.14, up about 7.5%, while its Class C shares (UA) ended at $4.93, up about 8.6%. 1

The disclosure matters because it puts a well-known, deep-pocketed shareholder on the tape at a time when investors have been debating whether Under Armour’s turnaround is stabilizing demand. Large, disclosed buying can also attract short-term traders looking for follow-through once regular trading begins.

It also signals intent. The investor filed a Schedule 13G/A — a disclosure typically used by holders who say they are passive investors, rather than seeking to influence control of a company.

In an amended Schedule 13G (Amendment No. 1), Watsa and Fairfax affiliates reported beneficial ownership of 30,454,445 Class A shares, representing 16.1% of that class. The filing listed Dec. 22, 2025 as the event date and was filed under Rule 13d-1(c), the section generally associated with passive ownership. 2

A separate Form 4 showed Fairfax-controlled entities bought Class A and Class C shares in a series of open-market purchases on Dec. 22, 23, 24, 26 and 29. The filing detailed purchases totaling about 11.15 million Class A shares and 4.54 million Class C shares at weighted-average prices ranging from about $4.36 to $4.73, implying roughly $71 million in buying based on those prices. 3

Under Armour has two main U.S.-listed share classes: Class A shares (UAA) carry voting rights, while Class C shares (UA) do not. The latest filings show Fairfax’s position spans both, with the Schedule 13G/A covering the voting Class A stock and the Form 4 reporting transactions and holdings in both classes.

The Form 4 listed Watsa as a director and 10% owner — categories that trigger insider transaction disclosures. It also said the shares were held through wholly owned subsidiaries of Fairfax Financial Holdings.

The buying comes with Under Armour still in the middle of a reset under founder Kevin Plank, who returned as CEO earlier in the turnaround. “Eighteen months into its turnaround plan, Under Armour appears to be struggling to navigate both a challenging external environment and internal missteps,” eMarketer analyst Sky Canaves said in a November report. 4

In that same November update, the company forecast full-year revenue and profit below Wall Street estimates and said it expected tariff-related costs to weigh on results, while also announcing a change in its chief financial officer role. 4

Competitive pressure remains intense across athletic apparel, where brands fight for discretionary spending and shelf space against larger players and fast-growing challengers. Investors have been quick to rotate between names on any sign of improving demand, fewer promotions or better inventory control.

For now, traders are watching whether Fairfax’s accumulation continues — another round of buying would likely show up in fresh SEC filings. Investors are also looking ahead to the next quarterly report; market calendars that track earnings dates list Feb. 5, 2026 as the expected next report date, though such dates can change and the company had not confirmed it in that listing. 5

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)
Previous Story

BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

SoFi stock dips in premarket as thin year-end trading keeps investors cautious
Next Story

SoFi stock dips in premarket as thin year-end trading keeps investors cautious

Go toTop